Treatment with the IDO inhibitor INCB024360 increased lysis of human tumor cell targets by peptide-specific CTL
暂无分享,去创建一个
M. Brechbiel | J. Schlom | P. Kim | R. Newton | K. Tsang | C. Jochems | Young-Seung Kim | M. Fantini | J. Hodge | S. Gameiro | A. Kwilas | S. Metenou | R. Fernando | Simon Metenou | Anna R. Kwilas | Sofia R. Gameiro
[1] E. Heath,et al. National Institutes of Health , 2019, The Grants Register 2022.